Does Dr. ZIV HASKAL have financial conflicts of interest?

Dr. ZIV HASKAL (M.D.) has received a total of $606,871 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $606,421 in personal promotional payouts (consulting, meals, travel) and $450 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ZIV HASKAL?

According to CMS Open Payments data, Dr. ZIV HASKAL received funding from BARD PERIPHERAL VASCULAR ($348,669), BOSTON SCIENTIFIC CORPORATION ($143,920), and SIRTEX MEDICAL ($86,486).

Does Dr. ZIV HASKAL receive research grants or speaking fees?

Dr. ZIV HASKAL has received $606,421 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $450 in clinical research grants.

DR. ZIV HASKAL

M.D.Real-Time Hydrated

Specialty: Radiology, Vascular & Interventional Radiology

Practice Location: CHARLOTTESVILLE, VA 22908

NPI Number: 1194760876

LIFETIME INDUSTRY VALUE

$606,871

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. HASKAL is a verified Radiology, Vascular & Interventional Radiology practitioner based in CHARLOTTESVILLE, VA.

Between 2021 and 2025, Dr. HASKAL had an overall industry promotional and research financial footprint of $606,871 as recorded in the federal CMS Open Payments database.

$606,421 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$450 was allocated to sponsored clinical trials and medical research activities.

Dr. HASKAL's primary funding source is BARD PERIPHERAL VASCULAR, which accounts for $348,669 (representing 57.5% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BARD PERIPHERAL VASCULAR

Rank 1

$348,669

57.5%

BOSTON SCIENTIFIC CORPORATION

Rank 2

$143,920

23.7%

SIRTEX MEDICAL

Rank 3

$86,486

14.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.